Originating from the embryonic neuroectoderm as neuroepithelial cells, neural stem cells generate neurons, astrocytes, and oligodendrocytes—the majority of the cells in the central nervous system. Neural stem cells have two primary functions: self-renewal and differentiation. This guide summarizes the most commonly used markers of neural stem cells and their immediate progeny.
Markers of Embryonic Neural Stem Cell Self-Renewal
Although the ultimate goal of any stem cell is to differentiate, all stem cell populations, including neural stem cells, must balance this fate with self-renewal. The process of self-renewal allows neural stem cell populations to expand and maintain their stemness, providing a continual source of new cells for differentiation when needed. The balance between differentiation and self-renewal is regulated by opposing transcriptional effectors.
The Notch signaling pathway is integral to this balance. Activation of the Notch 1 receptor leads to the expression of Hes1, Hes3, and Hes5—transcriptional repressors that inhibit proneural gene expression and promote pluripotency and self-renewal. With Notch activation, neural stem cells differentiate. The Hes family of transcription factors is not the only one touched by the Notch signaling pathway, however. The Gli (Gli1, Gli2, Gli3) and SoxB1 (Sox1, Sox2, Sox3) families of transcription factors also help foster pluripotency and self-renewal. Gli transcription factors do so by regulating the expression of Hes transcription factors downstream of Notch activation, whereas SoxB1 transcription factors do so by antagonizing proneural transcriptional effectors such as Ngn2 and ASCL1. SOX2 in particular is among the earliest markers of neural stem cell identity.
Other transcriptional regulators that regulate neural stem cell self-renewal include ID4 and HesR1/HesR2. The former promotes proliferation (but not pluripotency) and the latter represses neural differentiation.
Outside of transcriptional regulators, the filament protein neuroepithelial stem cell protein—or nestin, as it’s more commonly known—participates in neural stem cell survival and self-renewal.
Finally, the nonspecific proliferation markers BrdU (a thymidine analog that is incorporated into proliferating cells and can be detected by antibodies) and Ki67 (a nuclear protein universally associated with self-renewal) can also be used to triangulate neural stem cells, but only in combination with neural stem cell-specific markers.
Markers of Embryonic Neural Stem Cell Differentiation
Neural stem cell differentiation involves the downregulation of many of the self-renewal factors described above. This downregulation of self-renewal factors is accompanied by upregulation of proneural or proglial factors that drive the differentiation of neural stem cells into neurons, astrocytes, and oligodendrocytes.
The switch from radial glial cell to intermediate progenitor cell marks the first step in the process of differentiation. This switch occurs with the upregulation of transcriptional regulators Tbr1/Tbr2, Svet1, Cux1/Cux2, EMX2, FEZF2, and Ctip2. Tbr2 in particular is an exquisite marker of the intermediate progenitor cell stage of neural stem cell differentiation. Its expression is turned off in the next stage, and its expression in earlier stages (the radial glial cell stage) specifies intermediate progenitor cell identity.
Antibodies Search Tool Search Now Search our directory to find the right antibodies for your research needs.
Intermediate progenitor cells differentiate into neural progenitor cells, after which these cells differentiate into neurons and glia. These fates and the markers associated with them are outlined below.
Neuronal Differentiation
Neuronal differentiation is induced by neurogenic basic loop-helix-loop (bHLH) transcription factors, such as Ngn2 and Ascl1. As mentioned above, these transcription factors directly oppose transcriptional regulators of neural stem cell proliferation and self-renewal, such as SoxB1 family members.
The transcription factor Pax6 promotes neurogenesis and antagonizes self-renewal whether it’s expressed at high levels or not at all. High levels of Pax6 lead to increased interactions between Pax6 and proneural factors (such as Ascl1), whereas loss of Pax6 lowers the expression of cell cycle regulators, thereby promoting neurogenesis. Pax6 also controls the expression of Notch ligands and Hes5.
In the later stages of neuronal differentiation, neural stem cells begin to express the classical neuronal markers MAP2 and TUJ1. They also express vimentin, but this marker is also expressed by glia.
A number of cell surface markers of early neuronal commitment have been identified in vitro, including CD133, CD146, CD15, CD171, CD184, CD24, CD29, CD326, CD49d, and CDH1/CDH2. However, cell culture conditions, cell cycle phases, and cell sources (i.e. embryonic stem cells versus induced pluripotent stem cells) can influence the expression of these markers. These markers are more thoroughly discussed by De Gioia and colleagues (2020).
Astrocyte Differentiation
Gliogenesis is inhibited during neurogenesis by proneural bHLH transcription factors (e.g. Ngn2). Yet, during the process of neurogenesis, neural progenitor cells become receptive to gliogenic signals, enabling a gliogenic switch toward an astrocyte or oligodendrocyte fate. This switch is driven by gliogenic transcription factors Sox9, Olig1, and Olig2—all three of which support both astrocyte and oligodendrocyte differentiation. The neurogenic transcription factor Pax6 also plays a role in the maturation of astrocytes. The A2B5 antibody has been used to identify glial precursors.
A few markers can be used to infer astrocytic commitment in neural stem cells. GFAP is a commonly used marker of astrocytes, although it is not highly specific to these cells. Further, CD184, CD44, and CD49d have been identified as markers of astrocyte precursors in vitro.
Oligodendrocyte Differentiation
Markers of oligodendrocyte differentiation are better defined than those of astrocytic differentiation. In addition to the markers shared by astrocyte and oligodendrocyte precursors (discussed above), the latter also express Nkx2.2, Nkx6.2, PDGFA, and Sox10. PDGFA is a key determinant of oligodendrocyte fate as well as one of the most useful markers of oligodendrocyte progenitor cells.
Markers of Adult Neural Stem Cells
Neurogenesis persists into adulthood, although it is limited to the subgranular zone of the dentate gyrus of the hippocampus and the subventricular zone bordering the lateral ventricles. The transcriptional programs and markers that typify embryonic neurogenesis largely mirror those of adult neurogenesis. For example, Pax6, Hes family members, SoxB1 family members, neurogenic bHLH transcription factors, and Tbr2 all participate in both developmental phases.
Although the players are largely the same, the timing of expression differs slightly for some markers between embryonic and adult neurogenesis, as discussed by Christie and colleagues (2013).
Table of Neural Stem Cell Markers
The table below lists characteristic neural stem cell proteins as described by review literature. The list includes a variety of marker types, including transcription factors, cell surface proteins, and structural proteins. Accompanying each marker are links to relevant antibodies and ELISA kits that can be used to detect neural stem cells in vitro and in vivo. The associated products are offered by a variety of manufacturers and can serve as a useful reference for neural stem cell characterization.
Gene | Synonyms | Marker Type | Protein Type | Localization | Size (kDa) | Reference | Antibodies | ELISA Kits |
A2B5** |
|
Oligodendrocyte progenitor cell |
Non-Protein, Antibody |
- |
- |
2-6 |
A2B5 antibodies |
A2B5 ELISA |
ASCL1 |
Mash1 |
Neuronal and oligodendrocyte differentiation |
Transcription Factor |
Nuclear |
25.5 |
3,4 |
ASCL1 antibodies |
ASCL1 ELISA |
BCL11B |
Ctip2 |
Neural progenitor cell (NPC) differentiation |
Transcription Factor |
Nuclear |
95.5 |
3 |
BCL11B antibodies |
BCL11B ELISA |
BRDU** |
|
Self-renewal |
Non-Protein |
- |
- |
4 |
BRDU antibodies |
BRDU ELISA |
CD24 |
|
Neuronal differentiation |
Receptor |
Cell Membrane |
8.1 |
2,6 |
CD24 antibodies |
CD24 ELISA |
CD44 |
|
Neuronal differentiation (-), astrocyte differentiation (+) |
Receptor |
Cell Membrane |
81.5 |
2,5,6 |
CD44 antibodies |
CD44 ELISA |
CDH1 |
|
Neuronal differentiation |
Membrane Protein |
Golgi, Cell Membrane |
97.5 |
6 |
CDH1 antibodies |
CDH1 ELISA |
CDH2 |
|
Neuronal differentiation |
Membrane Protein |
Cell Membrane |
99.8 |
6 |
CDH2 antibodies |
CDH2 ELISA |
CUX1 |
|
NPC differentiation |
Transcription Factor |
Golgi |
77.5 |
3,4,6 |
CUX1 antibodies |
CUX1 ELISA |
CUX2 |
|
NPC differentiation |
Transcription Factor |
Nuclear |
161.7 |
3,4,6 |
CUX2 antibodies |
CUX2 ELISA |
CXCR4 |
CD184 |
Neuronal and astrocyte differentiation |
Receptor |
Cell Membrane |
39.7 |
2,6 |
CXCR4 antibodies |
CXCR4 ELISA |
EMX2 |
|
NPC differentiation |
Transcription Factor |
Nuclear |
28.3 |
4 |
EMX2 antibodies |
EMX2 ELISA |
EOMES |
Tbr2 |
NPC differentiation |
Transcription Factor |
Nuclear |
72.7 |
1,3,4 |
EOMES antibodies |
EOMES ELISA |
EPCAM |
CD326 |
Neuronal differentiation |
Membrane Glycoprotein |
Cell Membrane |
34.9 |
6 |
EPCAM antibodies |
EPCAM ELISA |
FEZF2 |
|
NPC differentiation |
Transcription Factor |
Nuclear |
48.8 |
3,4 |
FEZF2 antibodies |
FEZF2 ELISA |
FORSE-1* |
LeX Glycan |
Neuronal differentiation |
Non-Protein, Antibody |
- |
- |
6 |
antibodies |
ELISA |
FUT4 |
CD15 |
Neuronal differentiation |
Enzyme |
Cell Membrane |
59.1 |
2,6 |
FUT4 antibodies |
FUT4 ELISA |
GFAP |
|
Astrocyte differentiation |
Cytoskeletal Protein |
Cytoplasmic |
49.9 |
1,4,6 |
GFAP antibodies |
GFAP ELISA |
GLI1 |
|
Self-renewal |
Transcription Factor |
Nuclear, Cytoplasmic |
117.9 |
3 |
GLI1 antibodies |
GLI1 ELISA |
GLI2 |
|
Self-renewal |
Transcription Factor |
Nuclear, Cytoplasmic |
167.8 |
3 |
GLI2 antibodies |
GLI2 ELISA |
GLI3 |
|
Self-renewal |
Transcription Factor |
Nuclear, Cytoplasmic |
169.9 |
3 |
GLI3 antibodies |
GLI3 ELISA |
HES1 |
|
Self-renewal |
Transcription Factor |
Nuclear |
29.5 |
3,4,6 |
HES1 antibodies |
HES1 ELISA |
HES3 |
|
Self-renewal |
Transcription Factor |
Nuclear |
20 |
3,4,6 |
HES3 antibodies |
HES3 ELISA |
HES5 |
|
Self-renewal |
Transcription Factor |
Nuclear |
18.2 |
3,4,6 |
HES5 antibodies |
HES5 ELISA |
HEY1 |
HESR1 |
Self-renewal |
Transcription Factor |
Nuclear |
32.6 |
3 |
HEY1 antibodies |
HEY1 ELISA |
HEY2 |
HESR2 |
Self-renewal |
Transcription Factor |
Nuclear |
35.8 |
3 |
HEY2 antibodies |
HEY2 ELISA |
ID4 |
|
Self-renewal |
Transcription Factor |
Nuclear |
16.6 |
3 |
ID4 antibodies |
ID4 ELISA |
ITGA4 |
CD49d |
Neuronal and astrocyte differentiation |
Membrane protein |
Cell Membrane |
114.9 |
6 |
CD49d antibodies |
CD49d ELISA |
ITGB1 |
CD29 |
Neuronal differentiation |
Receptor |
Cell Membrane |
86.4 |
6 |
ITGB1 antibodies |
ITGB1 ELISA |
L1CAM |
CD171 |
Neuronal differentiation |
Cell Adhesion Molecule |
Cell Membrane |
140 |
6 |
L1CAM antibodies |
L1CAM ELISA |
LMO4 |
|
NPC differentiation |
Transcription Factor |
Nuclear |
18 |
3 |
LMO4 antibodies |
LMO4 ELISA |
MAP2 |
|
Neuronal differentiation |
Cytoskeletal Protein |
Cytoplasmic |
199.5 |
6 |
MAP2 antibodies |
MAP2 ELISA |
MCAM |
CD146 |
Neuronal differentiation |
Cell Adhesion Molecule |
Cell Membrane |
71.6 |
6 |
MCAM antibodies |
MCAM ELISA |
MKI67 |
KI67 |
Self-renewal |
Nuclear Protein |
Nuclear |
358.7 |
4 |
Ki-67 antibodies |
Ki-67 ELISA |
NES |
Nestin |
Self-renewal |
Cytoskeletal Protein |
Cytoplasmic |
177.4 |
1,2-6 |
nestin antibodies |
nestin ELISA |
NEUROG2 |
Ngn2 |
Neuronal differentiation |
Transcription Factor |
Nuclear |
28.6 |
3,4 |
NEUROG2 antibodies |
NEUROG2 ELISA |
NKX2-2 |
Nkx2.2 |
Oligodendrocyte differentiation |
Transcription Factor |
Nuclear |
30.1 |
3 |
NKX22 antibodies |
NKX22 ELISA |
NKX6-2 |
NKX6.2 |
Oligodendrocyte differentiation |
Transcription Factor |
Nuclear |
29.3 |
3 |
NKX6-2 antibodies |
NKX6-2 ELISA |
NOTCH1 |
|
Self-renewal |
Receptor |
Nuclear, Cell Membrane |
272.5 |
3,6 |
NOTCH1 antibodies |
NOTCH1 ELISA |
OLIG1 |
|
Oligodendrocyte and astrocyte differentiation |
Transcription Factor |
Nuclear |
27.9 |
3 |
OLIG1 antibodies |
OLIG1 ELISA |
OLIG2 |
|
Oligodendrocyte and astrocyte differentiation |
Transcription Factor |
Nuclear, Cytoplasmic |
32.4 |
3 |
OLIG2 antibodies |
OLIG2 ELISA |
PAX6 |
|
Self-renewal |
Transcription Factor |
Nuclear |
46.7 |
2-4,6 |
PAX6 antibodies |
PAX6 ELISA |
PDGFA |
CD140a |
Oligodendrocyte differentiation |
Receptor |
Secreted |
24 |
6 |
PDGFA antibodies |
PDGFA ELISA |
PROM1 |
CD133 |
Neuronal differentiation |
Membrane Glycoprotein |
Cell Membrane |
97.2 |
6 |
CD133 antibodies |
CD133 ELISA |
SATB2 |
|
Neuronal differentiation |
Transcription Factor |
Nuclear |
82.6 |
4 |
SATB2 antibodies |
SATB2 ELISA |
SOX1 |
|
Self-renewal |
Transcription Factor |
Nuclear |
39 |
2-4,6 |
SOX1 antibodies |
SOX1 ELISA |
SOX10 |
|
Oligodendrocyte differentiation |
Transcription Factor |
Nuclear, Cytoplasmic, Mitochondrial |
49.9 |
3,6 |
SOX10 antibodies |
SOX10 ELISA |
SOX2 |
|
Self-renewal |
Transcription Factor |
Nuclear |
34.3 |
1,3-6 |
SOX2 antibodies |
SOX2 ELISA |
SOX3 |
|
Self-renewal |
Transcription Factor |
Nuclear |
45.2 |
3 |
SOX3 antibodies |
SOX3 ELISA |
SOX5 |
|
Neuronal differentiation |
Transcription Factor |
Nuclear |
84 |
3,4 |
SOX5 antibodies |
SOX5 ELISA |
SOX9 |
|
Astrocyte and oligodendrocyte differentiation |
Transcription Factor |
Nuclear |
56.1 |
3 |
SOX9 antibodies |
SOX9 ELISA |
Svet1 |
|
NPC differentiation |
Transcription Factor |
- |
- |
3 |
antibodies |
ELISA |
TBR1 |
|
NPC differentiation |
Transcription Factor |
Nuclear |
74.1 |
1,3,4 |
TBR1 antibodies |
TBR1 ELISA |
TUBB3 |
Tuj1 |
Neuronal differentiation |
Cytoskeletal Protein |
Cytoplasmic |
50.4 |
4,6 |
TUBB3 antibodies |
TUBB3 ELISA |
VIM |
Vimentin |
Neuronal differentiation |
Cytoskeletal Protein |
Nuclear, Cytoplasmic, Cell Membrane |
53.7 |
4-6 |
vimentin antibodies |
vimentin ELISA |
Note: *A2B5 and FORSE-1 are antibody clones, not genes/proteins. **BRDU is a thymidine analog used to mark proliferating cells. Information on Protein Type, Localization, and Size (kDa) obtained from UniProt.org (for human genes only).
References
1. Duan X, Kang E, Liu CY, Ming GL, Song H. Development of neural stem cell in the adult brain. Curr Opin Neurobiol. 2008;18(1):108-115. doi:10.1016/j.conb.2008.04.001
2. Yuan SH, Martin J, Elia J, et al. Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells. PLoS One. 2011;6(3):e17540. doi:10.1371/journal.pone.0017540
3. Christie KJ, Emery B, Denham M, Bujalka H, Cate HS, Turnley AM. Transcriptional regulation and specification of neural stem cells. Adv Exp Med Biol. 2013;786:129-155. doi:10.1007/978-94-007-6621-1_8
4. Zhang J, Jiao J. Molecular Biomarkers for Embryonic and Adult Neural Stem Cell and Neurogenesis. Biomed Res Int. 2015;2015:727542. doi:10.1155/2015/727542
5. Vinci L, Ravarino A, Fanos V, et al. Immunohistochemical markers of neural progenitor cells in the early embryonic human cerebral cortex. Eur J Histochem. 2016;60(1):2563. doi:10.4081/ejh.2016.2563
6. De Gioia R, Biella F, Citterio G, et al. Neural Stem Cell Transplantation for Neurodegenerative Diseases. Int J Mol Sci. 2020;21(9):3103. doi:10.3390/ijms21093103